References
- Beresford A. P., Macrae P. V., Stopher D. A. Metabolism of amlodipine in the rat and the dog: a species difference. Xenobiotica 1988; 18: 169–182
- Guengerich F. P. Oxidative cleavage of carboxylic esters by cytochrome P-450. Journal of Biological Chemistry 1987; 262: 8459–8462
- Higuchi S., Sasaki H., Shiobara Y., Sado T. Absorption, excretion and metabolism of a new dihydropyridine diester cerebral vasodilator in rats and dogs. Xenobiotica 1977; 7: 469–479
- Hoffmann K.-J., Weidolf L. Identification of felodipine metabolites in rat urine. Biomedical Mass Spectrometry 1985; 12: 414–423
- Kamataki T., Maeda K., Shimada M., Kitani K., Nagai T., Kato R. Age-related alteration in the activities of drug, metabolizing enzymes and contents of sex-specific forms of cytochrome P-450 in liver microsomes from male and female rats. Journal of Pharmacology and Experimental Therapeutics 1985; 233: 222–228
- Medenwald H., Schlobmann K., Wünsche C. Strukturaufklärung der renalen Ausscheidungsprodukte von (4-(2′-Nitrophenyl)-2,6-dimethyl-1, 4-dihydropyridin-3,5-dicarbonsäuredimethylester. Arzneimittel-Forschung 1972; 22: 53–56
- Meyer H., Scherling D., Karl W. Nitrendipine:Identification and synthesis of main metabolic. Arzneimittel-Forschung 1983a; 33: 1528–1534
- Meyer H., Wehinger E., Bossert F., Scherling D. Nimodipine: Synthesis and metabolic pathway. Arzneimittel-Forschung 1983b; 33: 106–112
- Nishikibe M. Effect of the calcium entry blocker NB-818 on cerebral blood flow after unilateral carotid occlusion in the mongolian gerbil. Journal of Pharmacology and Experimental Therapeutics 1988; 246: 719–725
- Nishikibe M., Nagura J., Kamei K., Fukuroda T. Hemodynamic effects of a dihydropyridine calcium antagonist, NB-818 (NPK-1886) in anesthetized dogs. Archives international de Pharmacodynamie et de Therapie 1988; 291: 7–20
- Parinov V. J., Odinec A. G., Gilev A. P., Dubur G. J., Muceniece D. H., Ozol J. J., Shatz V. D., Gavars M. P., Vigante B. A. Pharmacokinetics and metabolism of ryodipine in rats. Arzneimittel-Forschung 1985; 35: 808–813
- Parker S. E., Weinstock J. Biotransformation of 1,4-dihydro-2,6-dimethyl-4-(2-trifluoromethylphenyl)-3,5-pyridinedicarboxylic acid diethyl ester. Journal of Medicinal Chemistry 1973; 16: 34–37
- Scherling D., Karl W., Ahr G., Ahr H. J., Wehinger E. Pharmacokinetics of nisoldipine III. Biotransformation of nisoldipine in rat, dog, monkey and man. Arzneimittel-Forschung 1988; 38: 1105–1110
- Takano T., Hata S. Selected ion monitoring analysis of NB-818, a new calcium entry blocker in a series of dihydropyridines, in human plasma. Biomedical and Environmental Mass Spectrometry 1988; 17: 477–482
- Terashita S., Tokuma Y., Fujiwara T., Shiokawa Y., Okumura K., Noguchi H. Metabolism of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs. Xenobiotica 1987; 17: 1415–1425
- Triggle D. J. In Calcium Blockers : Mechanism of Action and Clinical Applications, S. F. Flaim, R. Zelis. Urban and Schwarzenberg, Baltimore-Munich 1982; 121
- Walkenstein S. S., Intoccia A. P., Flanagan T. L., Hwang B., Flint D., Weinstock J., Villani A. J., Blackburn D., Green H. Metabolism of the antihypertensive agent 1,4-dihydro-2,6-dimethyl-4-(2-trifluoromethylphenyl)-3,5-pyridine dicarboxylic acid diethyl ester. Journal of Pharmaceutical Science 1973; 62: 580–584
- Waxman D. J., Dannan G. A., Guengerich F. P. Regulation of rat hepatic cytochrome P-450: Age-dependent expression, hormonal imprinting, and xenobiotic inducibility of sexspecific isoenzymes. Biochemistry 1985; 24: 4409–4417
- Weidolf L., Borg K. O., Hoffmann K.-J. Urinary metabolites of felodipine, a new vasodilator drug, in man, dog, rat and mouse. Xenobiotica 1984; 14: 657–666